Molecules 2014, 19
6066
Dimethyl 3-[1-(tert-Butyldimethylsilyl)-2-cyclopropylidenebut-3-en-1-ylidene]-2,3,5,6,7,7a-hexahydro-1H-
indene-1,1-dicarboxylate (13): Treatment of compound 9 (222 mg, 0.5 mmol) and bicyclopropylidene
(10, 80 mg, 1 mmol) according to GP1 for 14 h, after purification by column chromatography, eluting
with pentane/diethyl ether 9:1 (Rf = 0.36) gave 13 (162 mg, 73%) as a yellow oil. IR (film): 3054
1
(CH), 2953 (CH), 2857 (CH), 2739, 2708, 1734 (C=O), 1653 (C=C), 1093 cm−1 (C–O). H-NMR
(CDCl3): 6.5 (dd, J = 17.8 Hz, J = 10.5 Hz 1 H), 6.0 (t, J = 3.4 Hz, 1 H), 5.10 (dd, J = 1.9 Hz, J = 11.5 Hz,
1 H), 5.0 (dd, J = 1.9 Hz, J = 11.5 Hz, 1H ), 3.8 (s, 6 H, OCH3), 3.2 (t, J = 6.2 Hz, 1 H), 3.0 (m,
1 H), 2.8 (d, J = 16.2 Hz, 1 H), 2.0 (m, 2H), 1.6 (m, 2 H), 1.4 (m, 2 H), 1.2–1.0 (m, 4 H, Cpr), 0.9 (s,
13
9 H), 0.0 (s, 6 H). C-NMR (CDCl3): 172.2 (Cquat), 170.7 (Cquat), 147.6 (Cquat), 138.7 (Cquat), 137.8
(Cquat), 133.4 (Cquat), 131.3 (Cquat), 125.5, 124.9 (Cquat), 113, 6, 60.8, 52.5, 51.8, 47.2, 42.4, 28.1 (3xC),
+
26.4, 25.9, 21.8, 18.9 (Cquat), 4.09, −3.1 (2xC), 2.5. MS (DCI, NH3): m/z (%) = 905 (2M+NH4 , 18),
+
460.5 (M+NH4 , 100), 443.5 (M+H+, 60%), 347.4 (68), 327.2 (18), 300.2 (20). C26H38O4Si (442.7):
calcd. C 70.55, H 8.65; found C 70.48, H 8.72.
Dimethyl
3-(tert-Butyldimethylsilyl)-4-ethenyl-6,7,8,8a-tetrahydro-1H-spiro[acenaphthylene-5,1'
cyclopropane]-1,1-(2H,5aH)dicarboxylate (16): Treatment of compound 9 (222 mg, 0,5 mmol) and
bicyclopropylidene 10 (80 mg, 1 mmol) according to GP2 for 12 h, after purification by column
chromatography, eluting with pentane/diethyl ether 10:1 (Rf = 0.32) gave 16 (53 mg, 24%) as pale
yellow oil. IR (film): 2952 (CH), 2856 (CH), 1734 (C=O), 1654 (C=C), 1251, 1055 cm−1 (C–O).
1H-NMR (CDCl3): 6.1 (dd, J = 17.8 Hz, J = 11.5 Hz, 1 H), 5.8 (dd, J = 2.0 Hz, J = 11.5 Hz, 1 H), 4.8
(dd, J = 2.0 Hz, J = 11.5 Hz, 1 H), 3.8 (m, 1 H), 3.7 (s, 6 H), 3.0 (d, J = 2.6 Hz, 1 H), 2.82 (d,
J = 2.6 Hz, 1 H), 2.1 (brm, 1 H), 1.8 (m, 2 H), 1.6 (m, 2 H), 1.2 (m, 2 H), 0.9 (s, 9 H), 0.6–0.3 (m, 4 H,
13
Cpr), 0.0 (s, 6 H). C-NMR (CDCl3): 172.7 (Cquat), 170.7 (Cquat), 152.0 (Cquat), 139.2 (Cquat), 136.0,
128.2 (Cquat), 125.8 (Cquat), 119.1, 61.8 (Cquat), 52.6, 52.2, 45.5, 43.2, 34.1, 30.5, 27.8, 27.5 (3xC), 26.8,
+
21.4 (Cquat), 19.2 (Cquat), 16.3, 14.5,
̶
4.0 (2xC). MS (DCI, NH3): m/z (%) = 460.5 (M+NH4 , 82),
459.5 (M-H+NH4 , 100), 443.5 (M+H+, 60), 365.4 (85), 177.2 (85). C26H38O4Si (442.7): calcd. C
+
70.55, H 8.65; found C 70.54, H 8.65.
4. Conclusions
The new 2-bromo-2-en-6-ynes 3, 5 and 9 each containing a bromocyclohexene initiator, like
the previously investigated completely acyclic analogues, [32] undergo palladium-catalyzed
intra-intermolecular cascade cross coupling reactions in the presence of bicyclopropylidene 10 to give
indene analogues, conjugated tetraenes, 11, 12, 13 (in MeCN at 80 °C). The reaction, under different
conditions (in dimethylformamide at 110 °C) the desired spirocyclopropanated tricycle 16 was
obtained albeit in low yield (24%) and observed as an equimolar mixture of diastereomers, whereas
others 14, 15 were not fully isolated. Although the yield of spirocyclopropanated tricycle 16 was rather
disappointing, the concept of the 6π-electrocyclizations proved to be feasible on less strained
compounds. Additionally, an alternative palladium-mediated process rather than its free radical version
we studied before [33–35] give indene skeletons with higher yield.